RxDoctor Payments Data

Jennifer Tanner, PA

Physician Assistant · Louisville, GANPI 1710087101

Payments from drug & device makers

$1,051in general payments, 2019–2025

Across 62 payments — averaging $16.95 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Bayer$288
  • Novo Nordisk$268
  • AstraZeneca$126
  • Boehringer Ingelheim$63
  • Lundbeck LLC$57
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$40
  • plus $209 from 8 others

What the payments were for

  • Food & beverage$1,051100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,051 in reported general payments places this provider in the 65th percentile of 3,581 physician assistant providers in Georgia.

See all physician assistant providers in Georgia

Medicare billing

Part B allowed, 2024
$1,801
Medicare patients
14
Services billed
17

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin91$89,576
EliquisApixaban91$72,502
OzempicSemaglutide36$43,803
JanuviaSitagliptin Phosphate37$35,933
TrulicityDulaglutide33$35,327
Trelegy ElliptaFluticasone/Umeclidin/Vilanter26$30,448
XareltoRivaroxaban31$28,055
NulojixBelatacept13$26,446
KerendiaFinerenone22$20,712
RybelsusSemaglutide11$19,492
EntrestoSacubitril/Valsartan17$15,140
MounjaroTirzepatide11$11,569
LinzessLinaclotide16$10,757
FarxigaDapagliflozin Propanediol19$10,591
Tresiba Flextouch U-100Insulin Degludec16$8,168

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance, Stiolto Respimat$63$95,083103 claims
Novo NordiskOzempic, Rybelsus$268$63,29547 claims
Lilly USA, LLCTrulicity, Mounjaro$40$46,89544 claims
GSKTrelegy Ellipta$16$30,44826 claims
Johnson & JohnsonXarelto$16$28,05531 claims
BayerKerendia$288$20,71222 claims
NovartisEntresto$33$15,14017 claims
AstraZenecaFarxiga, Symbicort$126$14,90537 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 3,581 physician assistant providers in Georgia.

Other physician assistant in Louisville

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →